Acrivon Therapeutics, Inc. (ACRV)
1.615
-0.02
(-0.92%)
USD |
NASDAQ |
Mar 12, 16:00
1.615
0.00 (0.00%)
After-Hours: 19:08
Acrivon Therapeutics Total Assets (Quarterly) : 145.30M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aclarion, Inc. | 13.20M |
| Incyte Corp. | 6.971B |
| Karyopharm Therapeutics, Inc. | 117.46M |
| Erasca, Inc. | 420.40M |
| Humacyte, Inc. | 91.51M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.70M |
| Shareholders Equity (Quarterly) | 128.60M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 8.754 |
| Net Debt Paydown Yield | 0.43% |